Lincoln Pharmaceuticals Limited engages in manufacturing and trading of pharmaceutical products in India. The company offers products in the areas of anticold, antibiotic, otolaryngology, pain management, gastro, anti-malarial, anti-fungal, corticosteroids and cosmo-derma, anti-diabetic, anti-hypertensive, gynecology, cardio and CNS, respiratory system, and dyslipidemic; and branded generics. It also exports its products to approximately 60 countries, including Europe, Canada, Latin and North America, Africa, the Asia Pacific, and South East Asia. Lincoln Pharmaceuticals Limited was incorporated in 1979 and is based in Ahmedabad, India.
| Current Price | ₹589.70 |
|---|---|
| Market Cap | ₹1,181 Cr |
| Sector | Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals |
| Sub-Industry | Pharmaceuticals > Pharmaceutical Products |
| P/E Ratio | 13.4 |
| Return on Equity | 12.30% |
| 52-Week Range | ₹440.00 – ₹770.00 |
| Beta (1Y) | 0.42 |
| Dividend Yield | 0.31% |
Lincoln Pharmaceuticals Ltd. is trading at ₹589.70, with a market capitalisation of ₹1,181 Cr.
Lincoln Pharmaceuticals Ltd. operates in the Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals space (Pharmaceuticals > Pharmaceutical Products).
Lincoln Pharmaceuticals Ltd. has a P/E of 13.4 and a return on equity of 12.30%.